| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DMAC | Voting Common Shares, no par value per share | Award | $53,749 | +19,196 | +5.6% | $2.80 | 364,551 | 02 Jan 2024 | Direct | F1, F2 |
| holding | DMAC | Voting Common Shares, no par value per share | 25,573 | 02 Jan 2024 | See footnote | F3 | |||||
| holding | DMAC | Voting Common Shares, no par value per share | 21,070 | 02 Jan 2024 | By Spouse |
| Id | Content |
|---|---|
| F1 | These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $53,750. |
| F2 | Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 84,155 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 111,360 voting common shares held by Michael Giuffre individually. |
| F3 | These voting common shares are held by 424822 Albert Ltd, of which Michael Giuffre has sole voting and dispositive power. |